טוען...
Design and Evaluation of Tumor-Specific Dendrimer Epigenetic Therapeutics
Histone deacetylase inhibitors (HDACi) are promising therapeutics for cancer. HDACi alter the epigenetic state of tumors and provide a unique approach to treat cancer. Although studies with HDACi have shown promise in some cancers, variable efficacy and off-target effects have limited their use. To...
שמור ב:
| הוצא לאור ב: | ChemistryOpen |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4522184/ https://ncbi.nlm.nih.gov/pubmed/26246996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/open.201402141 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|